PubRank

Eng H Lo

Author PubWeight™ 246.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009 6.79
2 The science of stroke: mechanisms in search of treatments. Neuron 2010 6.14
3 Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 2006 5.10
4 Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008 3.83
5 Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 2003 3.10
6 A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005 2.58
7 Two-photon high-resolution measurement of partial pressure of oxygen in cerebral vasculature and tissue. Nat Methods 2010 2.37
8 Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002 2.30
9 Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006 2.27
10 Effects of neuroglobin overexpression on acute brain injury and long-term outcomes after focal cerebral ischemia. Stroke 2008 2.25
11 Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology 2012 2.19
12 Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 2004 2.13
13 Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 2008 2.10
14 MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 2008 2.08
15 Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc Natl Acad Sci U S A 2008 2.06
16 Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci 2003 2.05
17 Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004 1.93
18 Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain 2007 1.92
19 Cell-cell signaling in the neurovascular unit. Neurochem Res 2007 1.92
20 Stimulus-induced changes in blood flow and 2-deoxyglucose uptake dissociate in ipsilateral somatosensory cortex. J Neurosci 2008 1.89
21 Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J Neurosci 2006 1.85
22 Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J 2009 1.82
23 The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 2004 1.80
24 Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 2008 1.79
25 Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 2005 1.77
26 Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 2002 1.67
27 Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 2002 1.66
28 Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB. EMBO J 2004 1.65
29 An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J Neurosci 2009 1.62
30 Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol 2010 1.62
31 Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 2008 1.62
32 Green tea polyphenol (-)-epigallocatechin gallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia. J Neurosci Res 2009 1.60
33 Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2002 1.59
34 OCT methods for capillary velocimetry. Biomed Opt Express 2012 1.57
35 Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 2004 1.56
36 Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. J Cereb Blood Flow Metab 2006 1.56
37 Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol 2002 1.55
38 Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 2006 1.50
39 Experimental model of warfarin-associated intracerebral hemorrhage. Stroke 2008 1.48
40 Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 2005 1.47
41 Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 2007 1.47
42 Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. J Cereb Blood Flow Metab 2010 1.44
43 Hemoglobin-induced cytotoxicity in rat cerebral cortical neurons: caspase activation and oxidative stress. Stroke 2002 1.43
44 Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol 2005 1.42
45 Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol 2003 1.40
46 Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann N Y Acad Sci 2010 1.39
47 Relaxation-compensated fast multislice amide proton transfer (APT) imaging of acute ischemic stroke. Magn Reson Med 2008 1.39
48 Association between pH-weighted endogenous amide proton chemical exchange saturation transfer MRI and tissue lactic acidosis during acute ischemic stroke. J Cereb Blood Flow Metab 2011 1.36
49 Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 2007 1.35
50 Novel lipoxygenase inhibitors as neuroprotective reagents. J Neurosci Res 2008 1.34
51 Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes. Glia 2003 1.32
52 High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke 2010 1.30
53 Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke 2008 1.29
54 Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2009 1.27
55 Acute plasmalemma permeability and protracted clearance of injured cells after controlled cortical impact in mice. J Cereb Blood Flow Metab 2007 1.27
56 Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. Stroke 2009 1.26
57 Effects of neuroglobin overexpression on mitochondrial function and oxidative stress following hypoxia/reoxygenation in cultured neurons. J Neurosci Res 2009 1.25
58 Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke 2008 1.25
59 Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci U S A 2012 1.24
60 TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J Cereb Blood Flow Metab 2007 1.23
61 Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J Cereb Blood Flow Metab 2004 1.21
62 Infarct prediction and treatment assessment with MRI-based algorithms in experimental stroke models. J Cereb Blood Flow Metab 2006 1.20
63 Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab 2005 1.18
64 Mechanisms and targets for angiogenic therapy after stroke. Cell Adh Migr 2009 1.17
65 Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. J Cereb Blood Flow Metab 2002 1.15
66 12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress. J Neurochem 2009 1.13
67 Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1. J Neurotrauma 2009 1.12
68 Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. Stroke 2002 1.12
69 A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes. Stroke 2011 1.12
70 Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma 2002 1.11
71 Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage. Circulation 2011 1.10
72 Characterization of cerebrovascular responses to hyperoxia and hypercapnia using MRI in rat. Neuroimage 2008 1.10
73 Role of ERK map kinase and CRM1 in IL-1beta-stimulated release of HMGB1 from cortical astrocytes. Glia 2010 1.09
74 CD47 gene knockout protects against transient focal cerebral ischemia in mice. Exp Neurol 2009 1.09
75 Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling. J Neurosci Res 2010 1.08
76 Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells. J Neurosci 2011 1.08
77 Stratification of heterogeneous diffusion MRI ischemic lesion with kurtosis imaging: evaluation of mean diffusion and kurtosis MRI mismatch in an animal model of transient focal ischemia. Stroke 2012 1.07
78 Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury. Glia 2012 1.07
79 The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease. Pharmacol Ther 2013 1.07
80 Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice. Stroke 2013 1.07
81 Combination therapy targeting Akt and mammalian target of rapamycin improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2011 1.06
82 Oligovascular signaling in white matter stroke. Biol Pharm Bull 2009 1.06
83 Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage. Stroke 2011 1.06
84 Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro. Brain Res 2009 1.06
85 Plasmalemma permeability and necrotic cell death phenotypes after intracerebral hemorrhage in mice. Stroke 2011 1.06
86 Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke. Ann Neurol 2012 1.05
87 Cellular mechanisms of neurovascular damage and repair after stroke. J Child Neurol 2011 1.05
88 Stroke: working toward a prioritized world agenda. Stroke 2010 1.05
89 Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity. J Neurochem 2005 1.05
90 Pathophysiologic cascades in ischemic stroke. Int J Stroke 2012 1.03
91 Intracranial hemorrhage: mechanisms of secondary brain injury. Acta Neurochir Suppl 2011 1.03
92 Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice. J Neurotrauma 2010 1.03
93 Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury. J Clin Invest 2013 1.02
94 Optical coherence tractography using intrinsic contrast. Opt Lett 2012 1.02
95 Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12/15-lipoxygenase-dependent organelle damage pathway. J Cereb Blood Flow Metab 2010 1.02
96 Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. J Cereb Blood Flow Metab 2009 1.02
97 Multiparametric, longitudinal optical coherence tomography imaging reveals acute injury and chronic recovery in experimental ischemic stroke. PLoS One 2013 1.02
98 Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury. J Neurotrauma 2002 1.01
99 Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats. Stroke 2013 1.01
100 Stroke: working toward a prioritized world agenda. Cerebrovasc Dis 2010 1.01
101 Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators. Neurosci Lett 2007 1.01
102 Age-related decline in oligodendrogenesis retards white matter repair in mice. Stroke 2013 1.01
103 Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke. BMC Neurosci 2009 1.00
104 Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage. J Cereb Blood Flow Metab 2009 1.00
105 T time in the brain. Nat Med 2009 1.00
106 Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. J Cereb Blood Flow Metab 2010 1.00
107 The challenge of connecting the dots in the B.R.A.I.N. Neuron 2013 0.99
108 Neuroprotective roles and mechanisms of neuroglobin. Neurol Res 2009 0.99
109 Matrix metalloprotease regulation of neuropathic pain. Trends Pharmacol Sci 2009 0.99
110 Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy. CNS Neurol Disord Drug Targets 2008 0.98
111 Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes. Stroke 2006 0.98
112 Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy. Stroke 2010 0.98
113 Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases. CNS Neurol Disord Drug Targets 2013 0.98
114 Measurements of BOLD/CBV ratio show altered fMRI hemodynamics during stroke recovery in rats. J Cereb Blood Flow Metab 2005 0.97
115 Cortical excitation and inhibition following focal traumatic brain injury. J Neurosci 2011 0.97
116 Involvement of ERK MAP kinase in endoplasmic reticulum stress in SH-SY5Y human neuroblastoma cells. J Neurochem 2004 0.96
117 Crossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimaging. Neuroimage 2005 0.96
118 Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model. Stroke 2013 0.96
119 Neurovascular matrix metalloproteinases and the blood-brain barrier. Curr Pharm Des 2012 0.96
120 Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia. Stroke 2008 0.96
121 Neural stem cell transplant survival in brains of mice: assessing the effect of immunity and ischemia by using real-time bioluminescent imaging. Radiology 2006 0.95
122 Role of oxidative stress and caspase 3 in CD47-mediated neuronal cell death. J Neurochem 2008 0.94
123 Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside. Transl Stroke Res 2010 0.94
124 Injury and repair in the neurovascular unit. Neurol Res 2012 0.93
125 Neurovascular effects of CD47 signaling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro. J Neurosci Res 2009 0.93
126 Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases. Stroke 2012 0.93
127 Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes. Stroke 2008 0.91
128 Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes 2011 0.90
129 Neuroglobin is an endogenous neuroprotectant for retinal ganglion cells against glaucomatous damage. Am J Pathol 2011 0.90
130 Effects of normobaric oxygen on the progression of focal cerebral ischemia in rats. Exp Neurol 2013 0.90
131 Experimental models for analysis of oligodendrocyte pathophysiology in stroke. Exp Transl Stroke Med 2009 0.89
132 Validation of fast diffusion kurtosis MRI for imaging acute ischemia in a rodent model of stroke. NMR Biomed 2014 0.89
133 Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies. J Med Chem 2014 0.89
134 Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases. J Cereb Blood Flow Metab 2012 0.89
135 Interactions between p38 mitogen-activated protein kinase and caspase-3 in cerebral endothelial cell death after hypoxia-reoxygenation. Stroke 2003 0.89
136 The vasculome of the mouse brain. PLoS One 2012 0.89
137 Warfarin pretreatment reduces cell death and MMP-9 activity in experimental intracerebral hemorrhage. Transl Stroke Res 2014 0.88
138 Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells. Cerebrovasc Dis 2010 0.88
139 Neuregulin-1 effects on endothelial and blood-brain-barrier permeability after experimental injury. Transl Stroke Res 2012 0.88
140 Cerebral endothelial derived vascular endothelial growth factor promotes the migration but not the proliferation of oligodendrocyte precursor cells in vitro. Neurosci Lett 2012 0.88
141 Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size. Stroke 2013 0.87
142 Gene transfer of the Caenorhabditis elegans n-3 fatty acid desaturase inhibits neuronal apoptosis. J Neurochem 2002 0.87
143 Extracellular proteolytic pathophysiology in the neurovascular unit after stroke. Neurol Res 2004 0.87
144 Fast radio-frequency enforced steady state (FRESS) spin echo MRI for quantitative T2 mapping: minimizing the apparent repetition time (TR) dependence for fast T2 measurement. NMR Biomed 2011 0.87
145 Neuregulin-1 signaling in brain endothelial cells. J Cereb Blood Flow Metab 2008 0.87
146 Crosstalk between cerebral endothelium and oligodendrocyte. Cell Mol Life Sci 2013 0.86
147 Kollidon VA64, a membrane-resealing agent, reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2011 0.86
148 Traumatic brain injury during warfarin anticoagulation: an experimental study in mice. J Neurotrauma 2012 0.86
149 Delayed inhibition of c-Jun N-terminal kinase worsens outcomes after focal cerebral ischemia. J Neurosci 2012 0.85
150 Proteomic temporal profile of human brain endothelium after oxidative stress. Stroke 2010 0.85
151 Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes. Brain Res 2006 0.85
152 Effect of neuregulin-1 on histopathological and functional outcome after controlled cortical impact in mice. J Neurotrauma 2007 0.85
153 Dynamic functional cerebral blood volume responses to normobaric hyperoxia in acute ischemic stroke. J Cereb Blood Flow Metab 2012 0.85
154 Delivering minocycline into brain endothelial cells with liposome-based technology. J Cereb Blood Flow Metab 2012 0.85
155 Early elevation of serum tumor necrosis factor-α is associated with poor outcome in subarachnoid hemorrhage. J Investig Med 2012 0.85
156 Effects of tissue plasminogen activator and annexin A2 combination therapy on long-term neurological outcomes of rat focal embolic stroke. Stroke 2013 0.85
157 Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia. Neurobiol Dis 2009 0.84
158 Evaluation of plasma D-dimer plus fibrinogen in predicting acute CVST. Int J Stroke 2013 0.84
159 Vascular neuroprotection via TrkB- and Akt-dependent cell survival signaling. J Neurochem 2012 0.84
160 Stroke: working toward a prioritized world agenda. Int J Stroke 2010 0.84
161 Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms. J Neurochem 2015 0.84
162 Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol 2013 0.83
163 Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling. FASEB J 2012 0.83
164 Induction of vascular endothelial growth factor and matrix metalloproteinase-9 via CD47 signaling in neurovascular cells. Neurochem Res 2010 0.83
165 Stroke-related translational research. Arch Neurol 2011 0.83
166 Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage. Stroke 2011 0.83
167 Effect of normobaric oxygen therapy in a rat model of intracerebral hemorrhage. Stroke 2011 0.83
168 Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke. J Cereb Blood Flow Metab 2003 0.82
169 Reperfusion injury after stroke: neurovascular proteases and the blood-brain barrier. Handb Clin Neurol 2009 0.82
170 Advances in stroke neuroprotection: hyperoxia and beyond. Neuroimaging Clin N Am 2005 0.82
171 Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients. Mol Cell Proteomics 2013 0.81
172 Cerebral edema and a transtentorial brain herniation syndrome associated with pandemic swine influenza A (H1N1) virus infection. J Clin Neurosci 2011 0.81
173 fMRI of delayed albumin treatment during stroke recovery in rats: implication for fast neuronal habituation in recovering brains. J Cereb Blood Flow Metab 2006 0.81
174 γ-glutamylcysteine ethyl ester protects cerebral endothelial cells during injury and decreases blood-brain barrier permeability after experimental brain trauma. J Neurochem 2011 0.81
175 Studying extracellular signaling utilizing a glycoproteomic approach: lectin blot surveys, a first and important step. Methods Mol Biol 2013 0.81
176 Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography. Stroke 2013 0.81
177 The N-terminal ectodomain of Ninjurin1 liberated by MMP9 has chemotactic activity. Biochem Biophys Res Commun 2012 0.81
178 Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow. J Investig Med 2012 0.81
179 Cerebral blood oxygenation measurement based on oxygen-dependent quenching of phosphorescence. J Vis Exp 2011 0.81
180 Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity. Thromb Haemost 2013 0.81
181 Targeting the neurovascular unit in brain trauma. CNS Neurosci Ther 2014 0.80
182 Early insulin glycemic control combined with tPA thrombolysis reduces acute brain tissue damages in a focal embolic stroke model of diabetic rats. Stroke 2012 0.80
183 Advances in emerging nondrug therapies for acute stroke 2007. Stroke 2008 0.80
184 High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke. Acta Neurochir Suppl 2013 0.80
185 Neuroglobin-overexpression reduces traumatic brain lesion size in mice. BMC Neurosci 2012 0.80
186 Neurogenesis and apoptotic cell death. Stroke 2003 0.79
187 Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 2011 0.79
188 Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury. J Cereb Blood Flow Metab 2016 0.79
189 Lower doses of isoflurane treatment has no beneficial effects in a rat model of intracerebral hemorrhage. BMC Neurosci 2013 0.79
190 Combination stroke therapy: easy as APC? Nat Med 2004 0.78
191 Cerebrovascular degradation of TRKB by MMP9 in the diabetic brain. J Clin Invest 2013 0.78
192 Mechanisms and challenges in translational stroke research. J Investig Med 2016 0.78
193 Concussive injury before or after controlled cortical impact exacerbates histopathology and functional outcome in a mixed traumatic brain injury model in mice. J Neurotrauma 2013 0.78
194 Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice. PLoS One 2013 0.78
195 Opportunities and challenges in omics. Transl Stroke Res 2010 0.78
196 Corrigendum: Transfer of mitochondria from astrocytes to neurons after stroke. Nature 2016 0.77
197 First-order mathematical modeling of brain swelling in focal cerebral ischemia. Transl Stroke Res 2010 0.77
198 Neuregulin1-β decreases IL-1β-induced neutrophil adhesion to human brain microvascular endothelial cells. Transl Stroke Res 2014 0.77
199 Application of proteomics to cerebrovascular disease. Electrophoresis 2012 0.77
200 Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice. J Biol Chem 2013 0.77
201 Assays to examine endothelial cell migration, tube formation, and gene expression profiles. Methods Mol Biol 2014 0.76
202 Near infrared radiation protects against oxygen-glucose deprivation-induced neurotoxicity by down-regulating neuronal nitric oxide synthase (nNOS) activity in vitro. Metab Brain Dis 2015 0.76
203 Different strokes for rodent folks. Nat Methods 2006 0.76
204 Plasma biomarker may help to distinguish acute CVST from non-thrombotic CVSS in emergency. Int J Stroke 2012 0.75
205 Effects of Aging on Neural Stem/Progenitor Cells and Oligodendrocyte Precursor Cells After Focal Cerebral Ischemia in Spontaneously Hypertensive Rats. Cell Transplant 2016 0.75
206 Near infrared radiation rescues mitochondrial dysfunction in cortical neurons after oxygen-glucose deprivation. Metab Brain Dis 2014 0.75
207 Plasma-type gelsolin in subarachnoid hemorrhage: novel biomarker today, therapeutic target tomorrow? Crit Care 2014 0.75
208 Establishment of Cell-Based Neuroglobin Promoter Reporter Assay for Neuroprotective Compounds Screening. CNS Neurol Disord Drug Targets 2016 0.75
209 Erratum: opportunities and challenges in omics. Transl Stroke Res 2011 0.75